453 related articles for article (PubMed ID: 27890923)
61. Intragenic DNA methylation prevents spurious transcription initiation.
Neri F; Rapelli S; Krepelova A; Incarnato D; Parlato C; Basile G; Maldotti M; Anselmi F; Oliviero S
Nature; 2017 Mar; 543(7643):72-77. PubMed ID: 28225755
[TBL] [Abstract][Full Text] [Related]
62. Selective suppression of antisense transcription by Set2-mediated H3K36 methylation.
Venkatesh S; Li H; Gogol MM; Workman JL
Nat Commun; 2016 Nov; 7():13610. PubMed ID: 27892455
[TBL] [Abstract][Full Text] [Related]
63. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Linehan WM; Ricketts CJ
Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395
[TBL] [Abstract][Full Text] [Related]
64. Kidney cancer: The next decade.
Turajlic S; Swanton C; Boshoff C
J Exp Med; 2018 Oct; 215(10):2477-2479. PubMed ID: 30217855
[TBL] [Abstract][Full Text] [Related]
65. The Metabolic Basis of Kidney Cancer.
Linehan WM; Schmidt LS; Crooks DR; Wei D; Srinivasan R; Lang M; Ricketts CJ
Cancer Discov; 2019 Aug; 9(8):1006-1021. PubMed ID: 31088840
[TBL] [Abstract][Full Text] [Related]
66. Epidemiology of Renal Cell Carcinoma.
Capitanio U; Bensalah K; Bex A; Boorjian SA; Bray F; Coleman J; Gore JL; Sun M; Wood C; Russo P
Eur Urol; 2019 Jan; 75(1):74-84. PubMed ID: 30243799
[TBL] [Abstract][Full Text] [Related]
67. Oncometabolites in renal cancer.
Yong C; Stewart GD; Frezza C
Nat Rev Nephrol; 2020 Mar; 16(3):156-172. PubMed ID: 31636445
[TBL] [Abstract][Full Text] [Related]
68. Treatment of renal cell carcinoma: Current status and future directions.
Barata PC; Rini BI
CA Cancer J Clin; 2017 Nov; 67(6):507-524. PubMed ID: 28961310
[TBL] [Abstract][Full Text] [Related]
69. Renal cell carcinoma.
Hsieh JJ; Purdue MP; Signoretti S; Swanton C; Albiges L; Schmidinger M; Heng DY; Larkin J; Ficarra V
Nat Rev Dis Primers; 2017 Mar; 3():17009. PubMed ID: 28276433
[TBL] [Abstract][Full Text] [Related]
70. Epigenetics in renal cell cancer: mechanisms and clinical applications.
Joosten SC; Smits KM; Aarts MJ; Melotte V; Koch A; Tjan-Heijnen VC; van Engeland M
Nat Rev Urol; 2018 Jul; 15(7):430-451. PubMed ID: 29867106
[TBL] [Abstract][Full Text] [Related]
71. Renal cell carcinoma for the nephrologist.
Perazella MA; Dreicer R; Rosner MH
Kidney Int; 2018 Sep; 94(3):471-483. PubMed ID: 29661544
[TBL] [Abstract][Full Text] [Related]
72. Targeting the HIF2-VEGF axis in renal cell carcinoma.
Choueiri TK; Kaelin WG
Nat Med; 2020 Oct; 26(10):1519-1530. PubMed ID: 33020645
[TBL] [Abstract][Full Text] [Related]
73. Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
Klatte T; Rossi SH; Stewart GD
World J Urol; 2018 Dec; 36(12):1943-1952. PubMed ID: 29713755
[TBL] [Abstract][Full Text] [Related]
74. The immunology of renal cell carcinoma.
Díaz-Montero CM; Rini BI; Finke JH
Nat Rev Nephrol; 2020 Dec; 16(12):721-735. PubMed ID: 32733094
[TBL] [Abstract][Full Text] [Related]
75. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
Williamson SR; Gill AJ; Argani P; Chen YB; Egevad L; Kristiansen G; Grignon DJ; Hes O
Am J Surg Pathol; 2020 Jul; 44(7):e47-e65. PubMed ID: 32251007
[TBL] [Abstract][Full Text] [Related]
76. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma.
Vuong L; Kotecha RR; Voss MH; Hakimi AA
Cancer Discov; 2019 Oct; 9(10):1349-1357. PubMed ID: 31527133
[TBL] [Abstract][Full Text] [Related]
77. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes.
Braga EA; Fridman MV; Loginov VI; Dmitriev AA; Morozov SG
Front Genet; 2019; 10():320. PubMed ID: 31110513
[TBL] [Abstract][Full Text] [Related]
78. Renal Cell Carcinoma: Diagnosis and Management.
Gray RE; Harris GT
Am Fam Physician; 2019 Feb; 99(3):179-184. PubMed ID: 30702258
[TBL] [Abstract][Full Text] [Related]
79. Metabolic reprogramming in clear cell renal cell carcinoma.
Wettersten HI; Aboud OA; Lara PN; Weiss RH
Nat Rev Nephrol; 2017 Jul; 13(7):410-419. PubMed ID: 28480903
[TBL] [Abstract][Full Text] [Related]
80. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.
Jonasch E; Walker CL; Rathmell WK
Nat Rev Nephrol; 2021 Apr; 17(4):245-261. PubMed ID: 33144689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
